# Octapharma Plasma, Inc. – FDA Inspection, May 14, 2026

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/532ae937-43be-48d9-9259-d826a4616ee4
Source feed: FDA_Inspections

> FDA inspection 1318224 of Octapharma Plasma, Inc., May 14, 2026. 1 citation under 21 CFR part 606. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1318224
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2026-05-14
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Denver District Office
- Citation Count: 1

## Related Officers

- [Investigator](https://www.keypedia.com/people/garrad-r-poole/7fc97953-367e-459b-905d-25efe6ec39d2)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/1250700e-204f-4fe1-91f2-0500280f5abc

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face